Cue Biopharma Stock (NASDAQ: CUE) stock price, news, charts, stock research, profile.
Open | $0.56 |
Close | - |
Volume / Avg. | 26.18K / 438.08K |
Day Range | $0.55 - $0.56 |
52 Wk Range | 0.54 - 3.25 |
Market Cap | $27.48M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 34 |
Short Interest | 7.1% |
Days to Cover | 13.96 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Cue Biopharma (NASDAQ:CUE) through any online brokerage.
Other companies in Cue Biopharma’s space includes: Acurx Pharmaceuticals (NASDAQ:ACXP), Lumos Pharma (NASDAQ:LUMO), Bolt Biotherapeutics (NASDAQ:BOLT), Palatin Techs (AMEX:PTN) and Longeveron (NASDAQ:LGVN).
Cue Biopharma has a consensus price target of $8.71.
The stock price for Cue Biopharma (NASDAQ: CUE) is $0.5649 last updated September 19, 2024 at 10:35 AM EDT.
There are no upcoming dividends for Cue Biopharma.
Cue Biopharma’s Q3 earnings are confirmed for Friday, November 1, 2024.
There is no upcoming split for Cue Biopharma.
Cue Biopharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.